Post-Hospitalization Nursing Effectiveness (PHONE) Study

This study has been completed.
Sponsor:
Information provided by:
Wake Forest School of Medicine
ClinicalTrials.gov Identifier:
NCT00314431
First received: April 11, 2006
Last updated: NA
Last verified: April 2006
History: No changes posted
  Purpose

Based on success with telephone follow up for other groups of medically fragile infants, we designed an innovative model of post-hospital comprehensive and coordinated follow-up for infants with chronic lung disease. In this model, which we refer to as community-based follow-up, medical management was coordinated by a nurse specialist, through frequent telephone contacts with the infants’ primary caregiver. This model of follow up care was compared, in a randomized trial, with the more traditional model - multidisciplinary medical center-based care. We hypothesized that community-based care would lead to health and developmental outcomes similar to those observed with center-based care.


Condition Intervention Phase
Bronchopulmonary Dysplasia
Prematurity
Procedure: Care coordination by telephone contacts with a nurse
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Randomized Comparison of Two Models of Post-NICU Care for Preterm Infants With Neonatal Chronic Lung Disease

Resource links provided by NLM:


Further study details as provided by Wake Forest School of Medicine:

Primary Outcome Measures:
  • Bayley Scales of Infant Development-Second Edition

Secondary Outcome Measures:
  • Growth through one year of age
  • Rehospitalizations in the first year of life
  • Vineland Adaptive Behavioral Scales

Estimated Enrollment: 150
Study Start Date: May 1996
Estimated Study Completion Date: August 2000
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 483 Days
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Infants were eligible if they were born before 33 weeks gestational age, required supplemental oxygen at 36 weeks gestational age, and were discharged home after neonatal intensive care.

Exclusion Criteria:

  • Neonates who had major congenital anomalies and/ or had tracheostomy tubes were excluded. Also excluded were families in which the mother did not speak English, because the intervention depended on verbal communication with the nurse specialist, and families who lived more than 150 miles from our clinic because such families typically are referred to regional neonatal center closer to their home.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00314431

Locations
United States, North Carolina
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States, 27157
Sponsors and Collaborators
Wake Forest School of Medicine
Investigators
Principal Investigator: Thomas M O'Shea, MD, MPH Wake Forest School of Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00314431     History of Changes
Other Study ID Numbers: BG99547, R01 HS07928
Study First Received: April 11, 2006
Last Updated: April 11, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Wake Forest School of Medicine:
neonatal chronic lung disease
bronchopulmonary dysplasia
prematurity
telephone follow up
care coordination
children with special health care needs

Additional relevant MeSH terms:
Bronchopulmonary Dysplasia
Lung Diseases
Ventilator-Induced Lung Injury
Lung Injury
Respiratory Tract Diseases
Infant, Premature, Diseases
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on July 31, 2014